Citalopram hydrobromide and Lidocaine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Citalopram hydrobromide (citalopram hydrobromide) and Lidocaine hydrochloride (lidocaine hydrochloride). Common drug interactions include emotional distress among females and cold sweat among males.

The phase IV clinical study analyzes what interactions people have when they take Citalopram hydrobromide and Lidocaine hydrochloride. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,878 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Lidocaine hydrochloride?

Lidocaine hydrochloride has active ingredients of lidocaine hydrochloride. It is often used in pain. eHealthMe is studying from 5,876 Lidocaine hydrochloride users. Check the latest studies of Lidocaine hydrochloride.



On Jul, 08, 2026

45 people who take Citalopram hydrobromide and Lidocaine hydrochloride together, and have interactions are studied.

Citalopram hydrobromide and Lidocaine hydrochloride drug interactions.

What are the common drug interactions of Citalopram Hydrobromide and Lidocaine Hydrochloride, by gender? *:

female:

  1. Emotional distress
  2. Exostosis (formation of new bone on the surface of a bone)
  3. Gingival pain (gum pain)
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  5. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  6. Impaired healing
  7. Ingrowing nail
  8. Injury
  9. Intervertebral disc protrusion (spinal disc protrusion)
  10. Lumbar radiculopathy (radicular pain in the low back and legs)

male:

  1. Cold sweat
  2. Dizziness
  3. Atelectasis (partial or complete collapse of the lung)
  4. Back pain
  5. Bone disorder
  6. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Cellulitis (infection under the skin)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Citalopram Hydrobromide and Lidocaine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Weight increased
  2. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

20-29:

  1. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  2. Suicide attempt

30-39:

n/a

40-49:

n/a

50-59:

  1. Memory impairment
  2. Micturition urgency (urgency to pass the urine)
  3. Rectocele (a bulging of the front wall of the rectum into the back wall of the vagina)
  4. Staphylococcal infection (an infection with staphylococcus bacteria)
  5. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  6. Urinary tract infection
  7. Bone pain
  8. Constipation
  9. Dyspnoea (difficult or laboured respiration)
  10. Eye pain

60+:

  1. Dizziness
  2. Asthenia (weakness)
  3. Appetite disorder (abnormal eating habits)
  4. Arthralgia (joint pain)
  5. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Back pain
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  9. Chills (felling of cold)
  10. Constipation

What are the existing conditions these people have? *

  1. Hypercalcaemia (elevated calcium (ca+) level in the blood): 23 people, 51.11%
  2. Breast Cancer: 23 people, 51.11%
  3. Breast Cancer Metastatic: 22 people, 48.89%
  4. Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 10 people, 22.22%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and Lidocaine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Citalopram hydrobromide and Lidocaine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lidocaine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Citalopram hydrobromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidocaine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and lidocaine hydrochloride (the active ingredients of Citalopram hydrobromide and Lidocaine hydrochloride, respectively), and Citalopram hydrobromide and Lidocaine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: